Vanguard Group Inc Puma Biotechnology, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,643,422 shares of PBYI stock, worth $12.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,643,422
Previous 3,636,191
0.2%
Holding current value
$12.9 Million
Previous $9.27 Million
19.84%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding PBYI
# of Institutions
110Shares Held
28.3MCall Options Held
27.9KPut Options Held
3.4K-
Black Rock Inc. New York, NY3.57MShares$12.7 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY2.45MShares$8.7 Million6.49% of portfolio
-
Acadian Asset Management LLC Boston, MA1.97MShares$7 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.89MShares$6.72 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.76MShares$6.23 Million0.01% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $162M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...